
PharmaCielo Announces Sales Agreement with Brazilian Phyto-Therapeutic Customer, and Key Management and Board Appointments
July 28, 2022 TORONTO, Canada and RIONEGRO, Colombia (July 28, 2022) – PharmaCielo Ltd. (“PharmaCielo” or the“Company”) (TSXV: PCLO, OTCQX: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. ("Holdings"), today announced a